Geno'X Veille — genox-veille.fr
Week of 17 November 2026
Literature review — Pharmacogenomics
8
curated articles
0
score ≥ 8/10
Key takeaways this week
- ►GLP1R — among 13,725 treated adults, carriers of rare damaging variants lose less weight with semaglutide but keep a near-normal response with tirzepatide.
- ►Alcohol withdrawal with seizures — randomised trial of 100 patients: genotype-guided prescribing reduces excessive sedation (1/50 vs 9/50), but 48-hour stabilisation does not survive multiplicity correction.
- ►CYP2D6 — percentage allelic activity estimated in more than 7,000 patients deviates from categorical values and changes predicted Z-endoxifen concentrations by -22.3% to +40.0%.
- ►All of Us — 24.4% of nearly 100,000 participants have both an actionable pharmacogenomic phenotype and a prior exposure to an impacted medication.
- ►Asparaginase in children — systematic review of 40 studies: class II HLA alleles strongest for hypersensitivity, PNPLA3 for hepatotoxicity (three studies).
Weekly report in your inbox
Every Wednesday · Annotated selection · Free · Unsubscribe anytime
Articles of the week
8 articles of 8
Sort
CYP2D6
PubMedA Precise Activity System for Pharmacogenetics Based on Estimation of CYP2D6 Allelic Percentage Activity from the International CEPAM Database
Variability in exposure to CYP2D6-metabolised drugs (model: tamoxifen)
7
Clin Pharmacol Ther 2026· NovRead
Pharmacogenomic variation and medication exposure in a diverse general population
PubMedFrequency of pharmacogenomic variation and medication exposures among participants in the All of Us Research Program
Pharmacogenomic variation and medication exposure in a diverse general population
7
Sci Transl Med 2026· NovRead
GLP1R
PubMedRare GLP1R variants attenuate weight loss with semaglutide but not tirzepatide
Variability in weight loss with GLP-1 receptor agonists
6
Nat Metab 2026· NovRead
Alcohol withdrawal syndrome complicated by seizures
PubMedProspective genotype-guided drug selection and dosing in alcohol withdrawal syndrome complicated by seizures: a randomized clinical trial
Alcohol withdrawal syndrome complicated by seizures
6
Dose recommendation
Drug Metab Pers Ther 2026· NovRead
Implementation of pharmacogenomic services in adults aged 65 and over
PubMedAdvancing Precision Therapeutics in Older Adults: A Scoping Review of Pharmacogenomic Service Models
Implementation of pharmacogenomic services in adults aged 65 and over
6
Clin Pharmacol Ther 2026· NovRead
Oncology
PubMedPharmacogenomic Determinants of Asparaginase-Induced Hypersensitivity, Pancreatitis, Thrombosis, and Hepatotoxicity in Children: A Systematic Review
Asparaginase toxicities in children: hypersensitivity, pancreatitis, thrombosis, hepatotoxicity
6
OncologyAdverse reaction
Clin Pharmacol Ther 2026· NovRead
CYP3A5
PubMedThe impact of CYP3A5 genotype on tacrolimus pharmacokinetics in children following heart transplant
Tacrolimus pharmacokinetic variability after paediatric heart transplant
5
Dose recommendation
Pharmacogenomics J 2026· NovRead
Psychiatry
medRxivGenetic architecture and polygenic prediction of self-reported response to selective serotonin reuptake inhibitors in individuals with depression: a genome-wide meta-analysis
Response to selective serotonin reuptake inhibitors in depression
5
Psychiatry
medRxiv 2026· NovRead
References and sources
- CYP2D6 — Variability in exposure to CYP2D6-metabolised drugs (model: tamoxifen). Clin Pharmacol Ther 2026. PMID 43015984. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/43015984/
- Pharmacogenomic variation and medication exposure in a diverse general population. Sci Transl Med 2026. PMID 43013680. Score 7/10. https://pubmed.ncbi.nlm.nih.gov/43013680/
- GLP1R — Variability in weight loss with GLP-1 receptor agonists. Nat Metab 2026. PMID 43015368. Score 6/10. https://pubmed.ncbi.nlm.nih.gov/43015368/
- Alcohol withdrawal syndrome complicated by seizures. Drug Metab Pers Ther 2026. PMID 43037191. Score 6/10. https://pubmed.ncbi.nlm.nih.gov/43037191/
- Implementation of pharmacogenomic services in adults aged 65 and over. Clin Pharmacol Ther 2026. PMID 43004963. Score 6/10. https://pubmed.ncbi.nlm.nih.gov/43004963/
- Asparaginase toxicities in children: hypersensitivity, pancreatitis, thrombosis, hepatotoxicity. Clin Pharmacol Ther 2026. PMID 43023637. Score 6/10. https://pubmed.ncbi.nlm.nih.gov/43023637/
- CYP3A5 — Tacrolimus pharmacokinetic variability after paediatric heart transplant. Pharmacogenomics J 2026. PMID 43035491. Score 5/10. https://pubmed.ncbi.nlm.nih.gov/43035491/
- Response to selective serotonin reuptake inhibitors in depression. medRxiv 2026. doi:10.64898/2026.11.11.26367161. Score 5/10. https://www.medrxiv.org/content/10.64898/2026.11.11.26367161v1